Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
Karen L. Kotloff(University of Maryland, Baltimore), Myron M. Levine(University of Maryland, Baltimore)
PubMed
January 1, 1999
Cited by 1,263
Related Papers
Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet Infectious Diseases|2017|1.4k
Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study
|The Lancet|2019|923
Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis
|The Lancet Global Health|2019|551